These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1851518)

  • 41. Tyrosine kinase inhibitors: a potential approach to the treatment of hepatocellular carcinoma.
    Giannelli G; Napoli N; Antonaci S
    Curr Pharm Des; 2007; 13(32):3301-4. PubMed ID: 18045182
    [TBL] [Abstract][Full Text] [Related]  

  • 42. KIAA1199 promotes sorafenib tolerance and the metastasis of hepatocellular carcinoma by activating the EGF/EGFR-dependent epithelial-mesenchymal transition program.
    Xu Y; Xu H; Li M; Wu H; Guo Y; Chen J; Shan J; Chen X; Shen J; Ma Q; Liu J; Wang M; Zhao W; Hong J; Qi Y; Yao C; Zhang Q; Yang Z; Qian C; Li J
    Cancer Lett; 2019 Jul; 454():78-89. PubMed ID: 30980868
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Relationship between expression of decoy receptor 3 and apoptosis in hepatocellular carcinoma].
    Chen G; Luo DZ; Wang Y; Liao ZL; Zhang MY
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):113-7. PubMed ID: 17493386
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Direct interaction between surface β1,4-galactosyltransferase 1 and epidermal growth factor receptor (EGFR) inhibits EGFR activation in hepatocellular carcinoma.
    Tang W; Weng S; Zhang S; Wu W; Dong L; Shen X; Zhang S; Gu J; Xue R
    Biochem Biophys Res Commun; 2013 May; 434(3):449-54. PubMed ID: 23583406
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serine/arginine rich splicing factor 2 expression and clinic pathological features indicating a prognostic factor in human hepatocellular carcinoma patients.
    Wang P; Guo L; Li K; Ning S; Shi W; Liu Z; Chen Y
    Cancer Biomark; 2018 Feb; 21(3):681-687. PubMed ID: 29278882
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The expression of DJ-1 gene in human hepatocellular carcinoma and its relationship with tumor invasion and metastasis].
    Wu F; Liang YQ; Huang ZM
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):203-6. PubMed ID: 19335984
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LncRNA
    Zhang H; Luo C; Zhang G
    DNA Cell Biol; 2019 Aug; 38(8):857-864. PubMed ID: 31237446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin-like growth factor I receptor β expression in hepatocellular carcinoma.
    Liu X; Jiang W; Aucejo F; Kim R; Miller C; Byrne M; Lopez R; Yerian L
    Hum Pathol; 2011 Jun; 42(6):882-91. PubMed ID: 21292299
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ecto-5'-nucleotidase (CD73) is a potential target of hepatocellular carcinoma.
    Shali S; Yu J; Zhang X; Wang X; Jin Y; Su M; Liao X; Yu J; Zhi X; Zhou P
    J Cell Physiol; 2019 Jul; 234(7):10248-10259. PubMed ID: 30417547
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma.
    Inoue M; Takahashi Y; Fujii T; Kitagawa M; Fukusato T
    World J Gastroenterol; 2014 Dec; 20(46):17541-51. PubMed ID: 25516669
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction between heat shock protein 72 and alpha-fetoprotein in human hepatocellular carcinomas.
    Wang X; Zhou Y; Ying X; Guo L; Zhao Y; Fang Y
    Clin Chim Acta; 2007 Apr; 379(1-2):158-62. PubMed ID: 17250819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Afatinib, an EGFR inhibitor, decreases EMT and tumorigenesis of Huh‑7 cells by regulating the ERK‑VEGF/MMP9 signaling pathway.
    Chen Y; Chen X; Ding X; Wang Y
    Mol Med Rep; 2019 Oct; 20(4):3317-3325. PubMed ID: 31432165
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EGFR signaling confers resistance to BET inhibition in hepatocellular carcinoma through stabilizing oncogenic MYC.
    Yin Y; Sun M; Zhan X; Wu C; Geng P; Sun X; Wu Y; Zhang S; Qin J; Zhuang Z; Liu Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):83. PubMed ID: 30770740
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor.
    Wu YM; Liu CH; Hu RH; Huang MJ; Lee JJ; Chen CH; Huang J; Lai HS; Lee PH; Hsu WM; Huang HC; Huang MC
    Cancer Res; 2011 Dec; 71(23):7270-9. PubMed ID: 21990321
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of epidermal growth factor receptor and transforming growth factor-α on hepatitis C virus-induced hepatocarcinogenesis.
    Badawy AA; El-Hindawi A; Hammam O; Moussa M; Gabal S; Said N
    APMIS; 2015 Oct; 123(10):823-31. PubMed ID: 26279457
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nodules of less-differentiated tumor within or adjacent to hepatocellular carcinoma: relative expression of transforming growth factor-alpha and its receptor in the different areas of tumor.
    Morimitsu Y; Hsia CC; Kojiro M; Tabor E
    Hum Pathol; 1995 Oct; 26(10):1126-32. PubMed ID: 7557946
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma.
    Ito Y; Takeda T; Sakon M; Tsujimoto M; Higashiyama S; Noda K; Miyoshi E; Monden M; Matsuura N
    Br J Cancer; 2001 May; 84(10):1377-83. PubMed ID: 11355950
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunohistochemical demonstration of alpha-fetoprotein in small hepatocellular carcinoma.
    Sato K; Tanaka M; Kusaba T; Fukuda H; Tanikawa K
    Oncol Rep; 1998; 5(2):355-8. PubMed ID: 9468556
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
    Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Expression and clinical significance of Ephrin-A1 in primary hepatocellular carcinoma].
    Zhang G; Zhang SJ; Zhao YF; Wu Y; Li Z; Wang JX
    Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):499-502. PubMed ID: 17686315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.